← Back to all investments
HPA Exchange - Vital Medical Dallas TX DST property photo

HPA Exchange - Vital Medical Dallas TX DST

Sponsored by HPA Exchange
Minimum Investment$50,000
Total Offering$19,920,000
Available Equity$9,670,000 100.00% available
Equity$9,670,000
Debt$10,250,000
In-Place LTV51.46% LTV
Average Yield6.02%
Est. Tax-Adjusted Yield¹12.88%
Cap Rate Equivalent9.29%
LocationTX
Estimated Hold Period10 years
721 Exchange ExitOptional
Total Load16.62%
StrategyCore
StatusAvailable

Overview

$19.92M DST offering for an approximately 86,880-square-foot medical-office campus at 9505 and 9525 Greenville Avenue, Dallas, TX. The materials describe a long-term absolute-net healthcare lease and $9.67M of equity with $10.25M of debt.

Highlights

Approximately 86,880 SF medical-office campus.

9505 and 9525 Greenville Avenue, Dallas.

Reported 16-year lease with 2.5% escalations.

Absolute-net lease structure.

Children's hospital / specialty healthcare tenancy.

Analysis

Insights

Tenant credit, lease renewal, healthcare operations, pass-throughs, and exit value drive results.

Advantages

Long lease term, healthcare tenancy, absolute-net structure, and Dallas location.

Concerns

Tenant concentration, healthcare risk, debt risk, and illiquidity.

Projected Distributions

Average Yield6.02%
Est. Tax-Adjusted Yield¹12.88%
Cap Rate Equivalent9.29%
Y16.04%
Y26.31%
Y36.59%
Y46.92%
Y55.32%
Y65.31%
Y75.64%

Projected, not guaranteed. Distribution rates are the sponsor’s projections, are not a promise of performance, and can be reduced or suspended. ¹ Estimated Tax-Adjusted Yield reflects the projected impact of depreciation and amortization deductions at an assumed combined federal and state tax rate; individual tax outcomes vary — consult your CPA regarding your specific situation. Cap Rate Equivalent is a Baker 1031 Investments calculation intended to allow comparison with direct property ownership; it is not a sponsor-reported figure and does not represent a rate of return. See the private placement memorandum for the assumptions behind these figures.

Financing

LenderNot Disclosed
Interest RateNot Disclosed
Loan TermNot Disclosed
I/O PeriodNot Disclosed
AmortizationNot Disclosed
Y1 DSCRNot Disclosed

Benchmarks

Avg. Income
This deal6.02%
Market6.02%
Meets Average
Growth
This deal14.57%
Market14.57%
Meets Average
Peak
This deal6.92%
Market6.92%
Meets Average

Benchmarks compare this offering’s projected figures against sector medians computed across current offerings tracked by Baker 1031 Investments as of the last-updated date shown. Benchmark data is internal, unaudited, and subject to change.

Documents